Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 1950 and 1970 most of the decline in mortality rates from CVD was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medical treatments accounted for about half of the decline between 1980 and 2000 (Ford et al., 2007).”
From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Ford et al., 2007
In the citing paper
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
In the citing paper
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Research works printed but not linked: 3
- 2004, MMWR Morb Mortal Wkly Rep, 53, 82
- Ryan R, 2001, Health Stat Q, 12, 34
- Mokdad AH, 2003, MMWR Recomm Rep, 52, 1
Cited by
Items 201–300 of 1,006
Cardiovascular Drug Development
Fordyce, C. B., Roe, M. T., Ahmad, T., Libby, P., Borer, J. S., Hiatt, W. R., Bristow, M. R., Packer, M., Wasserman, S. M., Braunstein, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.016 · Cited by 202
Capewell, S., Ford, E. S., Croft, J. B., Critchley, J. A., Greenlund, K. J., & Labarthe, D. R. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.08.057885 · Cited by 200
Self-citationA 2020 Vision for Healthy People
Koh, H. K. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1001601 · Cited by 198
Barton, P., Andronis, L., Briggs, A., McPherson, K., & Capewell, S. (2011) · BMJ · doi:10.1136/bmj.d4044 · Cited by 195
Self-citationGidding, S. S., Lichtenstein, A. H., Faith, M. S., Karpyn, A., Mennella, J. A., Popkin, B., Rowe, J., Van Horn, L., & Whitsel, L. (2009) · Circulation · doi:10.1161/circulationaha.109.191856 · Cited by 190
Better Population Health Through Behavior Change in Adults: A Call to Action
Spring, B., Ockene, J. K., Gidding, S. S., Mozaffarian, D., Moore, S., Rosal, M. C., Brown, M. D., Vafiadis, D. K., Cohen, D. L., Burke, L. E., et al. (2013) · Circulation · doi:10.1161/01.cir.0000435173.25936.e1 · Cited by 195
Riley, R. F., Don, C. W., Powell, W., Maynard, C., & Dean, L. S. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958744 · Cited by 191
The Economic impact of Non-communicable Diseases on households in India
Engelgau, M. M., Karan, A., & Mahal, A. (2012) · Globalization and Health · doi:10.1186/1744-8603-8-9 · Cited by 189
Marma, A. K., Berry, J. D., Ning, H., Persell, S. D., & Lloyd-Jones, D. M. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.869727 · Cited by 195
Management of Statin Intolerance in 2018: Still More Questions Than Answers
Toth, P. P., Patti, A. M., Giglio, R. V., Nikolic, D., Castellino, G., Rizzo, M., & Banach, M. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0259-7 · Cited by 186
Localization of fat depots and cardiovascular risk
Gruzdeva, O., Borodkina, D., Uchasova, E., Dyleva, Y., & Barbarash, O. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0856-8 · Cited by 182
Banach, M., Duell, P. B., Gotto, A. M., Laufs, U., Leiter, L. A., Mancini, G. B. J., Ray, K. K., Flaim, J., Ye, Z., & Catapano, A. L. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.2314 · Cited by 187
Borghi, C., Agnoletti, D., Cicero, A. F. G., Lurbe, E., & Virdis, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.17956 · Cited by 173
Baron, S. L., Hein, M. J., Lehman, E., & Gersic, C. M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.050 · Cited by 185
Bollyky, T. J., Templin, T., Cohen, M., Schoder, D., Dieleman, J. L., & Wigley, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30235-1 · Cited by 189
Li, Y., Burrows, N. R., Gregg, E. W., Albright, A., & Geiss, L. S. (2012) · Diabetes Care · doi:10.2337/dc11-1360 · Cited by 188
Saydah, S., Bullard, K. M., Cheng, Y., Ali, M. K., Gregg, E. W., Geiss, L., & Imperatore, G. (2014) · Obesity · doi:10.1002/oby.20761 · Cited by 180
Technology Diffusion and Productivity Growth in Health Care
Skinner, J., & Staiger, D. (2015) · Review of Economics and Statistics · doi:10.1162/rest_a_00535 · Cited by 185
Mancini, G. B. J., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D., & Pope, J. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.05.007 · Cited by 188
Xu, H., Cupples, L. A., Stokes, A., & Liu, C.-T. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.4587 · Cited by 182
Untangling the relationship between medication adherence and post–myocardial infarction outcomes
Choudhry, N. K., Glynn, R. J., Avorn, J., Lee, J. L., Brennan, T. A., Reisman, L., Toscano, M., Levin, R., Matlin, O. S., Antman, E. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.09.014 · Cited by 178
Mortality patterns in hypertension
Arima, H., Barzi, F., & Chalmers, J. (2011) · Journal of Hypertension · doi:10.1097/01.hjh.0000410246.59221.b1 · Cited by 185
Homoarginine, Cardiovascular Risk, and Mortality
März, W., Meinitzer, A., Drechsler, C., Pilz, S., Krane, V., Kleber, M. E., Fischer, J., Winkelmann, B. R., Böhm, B. O., Ritz, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.908988 · Cited by 185
Ford, E. S. (2011) · Circulation · doi:10.1161/circulationaha.110.005645 · Cited by 183
Self-citationTrends in Out-of-Hospital Deaths Due to Coronary Heart Disease in Sweden (1991 to 2006)
Dudas, K., Lappas, G., Stewart, S., & Rosengren, A. (2011) · Circulation · doi:10.1161/circulationaha.110.964999 · Cited by 183
Trends in Cause of Death After Percutaneous Coronary Intervention
Spoon, D. B., Psaltis, P. J., Singh, M., Holmes, D. R., Gersh, B. J., Rihal, C. S., Lennon, R. J., Moussa, I. D., Simari, R. D., & Gulati, R. (2014) · Circulation · doi:10.1161/circulationaha.113.006518 · Cited by 184
Variations in amenable mortality—Trends in 16 high-income nations
Nolte, E., & McKee, M. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.08.002 · Cited by 177
McNamara, R. L., Spatz, E. S., Kelley, T. A., Stowell, C. J., Beltrame, J., Heidenreich, P., Tresserras, R., Jernberg, T., Chua, T., Morgan, L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001767 · Cited by 179
Chronic burden of near-roadway traffic pollution in 10 European cities (APHEKOM network)
Perez, L., Declercq, C., Iñiguez, C., Aguilera, I., Badaloni, C., Ballester, F., Bouland, C., Chanel, O., Cirarda, F. B., Forastiere, F., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00031112 · Cited by 170
Mozaffarian, D., Marfisi, R., Levantesi, G., Silletta, M. G., Tavazzi, L., Tognoni, G., Valagussa, F., & Marchioli, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61343-9 · Cited by 179
Bandosz, P., O'Flaherty, M., Drygas, W., Rutkowski, M., Koziarek, J., Wyrzykowski, B., Bennett, K., Zdrojewski, T., & Capewell, S. (2012) · BMJ · doi:10.1136/bmj.d8136 · Cited by 171
Self-citationCardiovascular disease and modifiable cardiometabolic risk factors
Cannon, C. P. (2007) · Clinical Cornerstone · doi:10.1016/s1098-3597(07)80025-1 · Cited by 175
Patient Cost-Sharing and Healthcare Spending Growth
Baicker, K., & Goldman, D. (2011) · Journal of Economic Perspectives · doi:10.1257/jep.25.2.47 · Cited by 170
Setoguchi, S., Glynn, R. J., Avorn, J., Mittleman, M. A., Levin, R., & Winkelmayer, W. C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.063 · Cited by 178
Cao, B., Bray, F., Ilbawi, A., & Soerjomataram, I. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30411-x · Cited by 169
Dyslipidemia and Pediatric Obesity
Cook, S., & Kavey, R. E. W. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.09.003 · Cited by 165
Status of Cardiovascular Health in Chinese Adults
Bi, Y., Jiang, Y., He, J., Xu, Y., Wang, L., Xu, M., Zhang, M., Li, Y., Wang, T., Dai, M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.044 · Cited by 175
Ischaemic heart disease in Africa
Mensah, G. A. (2008) · Heart · doi:10.1136/hrt.2007.136523 · Cited by 170
Lonn, E., Bosch, J., Teo, K. K., Pais, P., Xavier, D., & Yusuf, S. (2010) · Circulation · doi:10.1161/circulationaha.109.873232 · Cited by 174
Nicolau, J. C., Feitosa, G. S., Petriz, J. L. F., Furtado, R. H. D. M., Précoma, D. B., Lemke, W., Lópes, R. D., Timerman, A., Marin‐Neto, J. A., Bezerra, L., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210180 · Cited by 322
Social Determinants and the Decline of Cardiovascular Diseases: Understanding the Links
Harper, S., Lynch, J., & Smith, G. D. (2011) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031210-101234 · Cited by 168
Franco, M., Ordunez, P., Caballero, B., Tapia Granados, J. A., Lazo, M., Bernal, J. L., Guallar, E., & Cooper, R. S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm226 · Cited by 166
Engblom, H., Xue, H., Akil, S., Carlsson, M., Hindorf, C., Oddstig, J., Hedeer, F., Hansen, M. S., Aletras, A. H., Kellman, P., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0388-9 · Cited by 165
Heart Disease Death Rates Among Blacks and Whites Aged ≥35 Years — United States, 1968–2015
Van Dyke, M., Greer, S., Odom, E., Schieb, L., Vaughan, A., Kramer, M., & Casper, M. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6705a1 · Cited by 165
Mannsverk, J., Wilsgaard, T., Mathiesen, E. B., Løchen, M.-L., Rasmussen, K., Thelle, D. S., Njølstad, I., Hopstock, L. A., & Bønaa, K. H. (2016) · Circulation · doi:10.1161/circulationaha.115.016960 · Cited by 162
O'Flaherty, M., Buchan, I., & Capewell, S. (2013) · Heart · doi:10.1136/heartjnl-2012-302300 · Cited by 165
Self-citationThe impact of universal National Health Insurance on population health: the experience of Taiwan
Lee, Y.-C., Huang, Y.-T., Tsai, Y.-W., Huang, S.-M., Kuo, K. N., McKee, M., & Nolte, E. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-225 · Cited by 163
Bajekal, M., Scholes, S., Love, H., Hawkins, N., O'Flaherty, M., Raine, R., & Capewell, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001237 · Cited by 158
Self-citationRecent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology
Kandaswamy, E., & Zuo, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020424 · Cited by 180
Cheng, S., Claggett, B., Correia, A. W., Shah, A. M., Gupta, D. K., Skali, H., Ni, H., Rosamond, W. D., Heiss, G., Folsom, A. R., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.008506 · Cited by 160
Khera, R., Valero-Elizondo, J., Das, S. R., Virani, S. S., Kash, B. A., de Lemos, J. A., Krumholz, H. M., & Nasir, K. (2019) · Circulation · doi:10.1161/circulationaha.119.041974 · Cited by 157
An Electrocardiogram Should Not Be Included in Routine Preparticipation Screening of Young Athletes
Chaitman, B. R. (2007) · Circulation · doi:10.1161/circulationaha.107.711465 · Cited by 164
Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
Farkouh, M. E., Boden, W. E., Bittner, V., Muratov, V., Hartigan, P., Ogdie, M., Bertolet, M., Mathewkutty, S., Teo, K., Maron, D. J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.044 · Cited by 162
The World Heart Federation's vision for worldwide cardiovascular disease prevention
Yusuf, S., Wood, D., Ralston, J., & Reddy, K. S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60265-3 · Cited by 180
Adolescence Risk Factors Are Predictive of Coronary Artery Calcification at Middle Age
Hartiala, O., Magnussen, C. G., Kajander, S. A., Knuuti, J. M., Ukkonen, H., Saraste, A., Rinta-Kiikka, I. C., Kainulainen, S., Kähönen, M. A. P., Hutri‐Kähönen, N., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.045 · Cited by 177
Bonicalzi, M.-È., Haince, J.-F., Droit, A., & Poirier, G. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4505-1 · Cited by 171
WRITING COMMITTEE MEMBERS, Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C., Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd-Jones, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192617 · Cited by 155
Self-citationChernew, M. E., & Newhouse, J. P. (2011) · Handbook of health economics · doi:10.1016/b978-0-444-53592-4.00001-3 · Cited by 195
Why are we failing to implement effective therapies in cardiovascular disease?
Nieuwlaat, R., Schwalm, J.-D., Khatib, R., & Yusuf, S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs481 · Cited by 152
Resource Effective Strategies to Prevent and Treat Cardiovascular Disease
Schwalm, J.-D., McKee, M., Huffman, M. D., & Yusuf, S. (2016) · Circulation · doi:10.1161/circulationaha.115.008721 · Cited by 172
Oxidative Stress in Ischemic Heart Disease
Kibel, A., Lukinac, A. M., Dambic, V., Juric, I., & Selthofer-Relatic, K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6627144 · Cited by 144
Impact of Sugar-Sweetened Beverages on Blood Pressure
Malik, A. H., Akram, Y., Shetty, S. S., Malik, S., & Njike, V. Y. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.437 · Cited by 164
Chen, J., Normand, S.-L. T., Wang, Y., Drye, E. E., Schreiner, G. C., & Krumholz, H. M. (2010) · Circulation · doi:10.1161/circulationaha.109.862094 · Cited by 152
Ernstsen, L., Strand, B. H., Nilsen, S. M., Espnes, G. A., & Krokstad, S. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-266 · Cited by 160
Foldyna, B., Udelson, J. E., Karády, J., Banerji, D., Lu, M. T., Mayrhofer, T., Bittner, D. O., Meyersohn, N. M., Emami, H., Genders, T. S. S., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jey182 · Cited by 162
Population Trends of Recurrent Coronary Heart Disease Event Rates Remain High
Briffa, T. G., Hobbs, M. S., Tonkin, A., Sanfilippo, F. M., Hickling, S., Ridout, S. C., & Knuiman, M. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.957944 · Cited by 148
Cook, N. R., & Ridker, P. M. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5336 · Cited by 148
Strand, B. H., Groholt, E.-K., Steingrimsdottir, O. A., Blakely, T., Graff-Iversen, S., & Naess, O. (2010) · BMJ · doi:10.1136/bmj.c654 · Cited by 143
Non-communicable diseases and injuries in Pakistan: strategic priorities
Jafar, T. H., Haaland, B. A., Rahman, A., Razzak, J., Bilger, M., Naghavi, M., Mokdad, A. H., & Hyder, A. A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60646-7 · Cited by 184
Tobacco Smoke Induces the Generation of Procoagulant Microvesicles From Human Monocytes/Macrophages
Li, M., Yu, D., Williams, K. J., & Liu, M. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209577 · Cited by 155
Mansur, A. D. P., & Favarato, D. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2012005000061 · Cited by 146
Webber, B. J., Seguin, P. G., Burnett, D. G., Clark, L. L., & Otto, J. L. (2012) · JAMA · doi:10.1001/jama.2012.70830 · Cited by 142
Trends in health of older adults in the United States: Past, present, future
Martin, L. G., Schoeni, R. F., & Andreski, P. M. (2010) · Demography · doi:10.1353/dem.2010.0003 · Cited by 141
Berger, J. S., Lala, A., Krantz, M. J., Baker, G. S., & Hiatt, W. R. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.04.006 · Cited by 161
Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach
O’Keefe, J. H., Carter, M. D., & Lavie, C. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.8.741 · Cited by 173
Cardiac Cell Repair Therapy: A Clinical Perspective
Gersh, B. J., Simari, R. D., Behfar, A., Terzic, C. M., & Terzic, A. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.10.876 · Cited by 149
Keyhani, S., Scobie, J. V., Hebert, P. L., & McLaughlin, M. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107342 · Cited by 143
Cardiovascular risk assessment: a global perspective
Zhao, D. H., Liu, J., Xie, W., & Qi, Y. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.28 · Cited by 158
Cusimano, M. C., Pudwell, J., Roddy, M., Cho, C.-K. J., & Smith, G. N. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.12.001 · Cited by 150
Miranda, J. J., Herrera, V., Chirinos, J. A., Gómez, L. F., Perel, P., Pichardo, R. N., González, A., Sánchez, J. R., Catterina Ferreccio, R., Aguilera, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054056 · Cited by 143
Challenges and Opportunities for Cardiovascular Disease Prevention
Franco, M., Cooper, R., Bilal, U., & Fuster, V. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.08.015 · Cited by 165
Lauffenburger, J. C., Robinson, J. G., Oramasionwu, C., & Fang, G. (2014) · Circulation · doi:10.1161/circulationaha.113.002658 · Cited by 140
Trends in the Leading Causes of Death in Korea, 1983-2012
Lim, D., Ha, M., & Song, I. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.12.1597 · Cited by 139
Abdominal Obesity and Cardiovascular Disease: Is Inflammation the Missing Link?
Després, J. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.004 · Cited by 167
Jousilahti, P., Laatikainen, T., Peltonen, M., Borodulin, K., Männistö, S., Jula, A., Salomaa, V., Harald, K., Puska, P., & Vartiainen, E. (2016) · BMJ · doi:10.1136/bmj.i721 · Cited by 121
Beltran-Sanchez, H., Preston, S., & Canudas-Romo, V. (2008) · Demographic Research · doi:10.4054/demres.2008.19.35 · Cited by 136
Assessing Physical Activity and its Relationship to Cardiovascular Risk Factors: NHANES 2003-2006
Luke, A., Dugas, L. R., Durazo-Arvizu, R. A., Cao, G., & Cooper, R. S. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-387 · Cited by 135
Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease
Berger, J. S., Bhatt, D. L., Steinhubl, S. R., Shao, M., Steg, P. G., Montalescot, G., Hacke, W., Fox, K. A. A., Lincoff, A. M., Topol, E. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.866533 · Cited by 144
Role of Sodium and Calcium Dysregulation in Tachyarrhythmias in Sudden Cardiac Death
Wagner, S., Maier, L. S., & Bers, D. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.304678 · Cited by 148
Li, S., Fonarow, G. C., Mukamal, K., Xu, H., Matsouaka, R. A., Devore, A. D., & Bhatt, D. L. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008088 · Cited by 127
Kociol, R. D., Lópes, R. D., Clare, R. M., Thomas, L. E., Mehta, R. H., Kaul, P., Pieper, K. S., Hochman, J. S., Weaver, W. D., Armstrong, P. W., et al. (2012) · JAMA · doi:10.1001/jama.2011.1926 · Cited by 137
The Association of Coronary Artery Calcium With Noncardiovascular Disease
Handy, C. E., Desai, C. S., Dardari, Z. A., Al-Mallah, M. H., Miedema, M. D., Ouyang, P., Budoff, M. J., Blumenthal, R. S., Nasir, K., & Blaha, M. J. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.09.020 · Cited by 131
Redfern, J., Hyun, K. K., Chew, D. P., Astley, C. M., Chow, C. K., Aliprandi‐Costa, B., Howell, T. E., Carr, B., Lintern, K. J., Ranasinghe, I., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305296 · Cited by 130
Sinha, S. S., Sjoding, M. W., Sukul, D., Prescott, H. C., Iwashyna, T. J., Gurm, H. S., Cooke, C. R., & Nallamothu, B. K. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003616 · Cited by 126
Las enfermedades crónicas no transmisibles en México: sinopsis epidemiológica y prevención integral
Córdova-Villalobos, J. Á., Barriguete-Meléndez, J. A., Lara-Esqueda, A., Barquera, S., Rosas-Peralta, M., Hernández-Ávila, M., León-May, M. E. D., Admon, L., & Aguilar-Salinas, C. A. (2008) · Salud Pública de México · doi:10.1590/s0036-36342008000500015 · Cited by 130
Comprehensive Cardiovascular Risk Factor Control Improves Survival
Bittner, V., Bertolet, M., Barraza Felix, R., Farkouh, M. E., Goldberg, S., Ramanathan, K. B., Redmon, J. B., Sperling, L., & Rutter, M. K. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.019 · Cited by 127
Linke, S. E., Rutledge, T., Johnson, B. D., Vaccarino, V., Bittner, V., Cornell, C. E., Eteiba, W., Sheps, D. S., Krantz, D. S., Parashar, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.27 · Cited by 126
Global Dietary Surveillance: Data Gaps and Challenges
Micha, R., Coates, J., Leclercq, C., Charrondière, U. R., & Mozaffarian, D. (2018) · Food and Nutrition Bulletin · doi:10.1177/0379572117752986 · Cited by 146
Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease
Carrillo, M. C., Brashear, H. R., Logovinsky, V., Ryan, J. M., Feldman, H. H., Siemers, E. R., Abushakra, S., Hartley, D. M., Petersen, R. C., Khachaturian, A. S., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.12.004 · Cited by 124
Popa, C. D., van Tits, L. J. H., Barrera, P., Lemmers, H., van den Hoogen, F. H. J., van Riel, P. L. C. M., Radstake, T. R. D. J., Netea, M. G., Roest, M., & Stalenhoef, A. F. H. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092171 · Cited by 128
Metadata
- Authors
- Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Newcastle University (GB)
- HealthPartners (US)
- University of Liverpool (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-07
- Volume
- 356
- Issue
- 23
- Pages
- 2388-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150278133
- Cited by
- 2,757
- References
- 44
- Citations by year
- 2026: 56 · 2025: 66 · 2024: 60 · 2023: 82 · 2022: 100 · 2021: 101 · 2020: 114 · 2019: 129 · 2018: 129 · 2017: 153 · 2016: 163 · 2015: 209 · 2014: 173 · 2013: 198 · 2012: 252
- FWCI
- 127.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- coronary heart disease mortality, mortality decline, cardiovascular risk factors, IMPACT model, secondary prevention after myocardial infarction, revascularization, acute myocardial infarction treatment, unstable angina, heart failure treatment, cholesterol lowering, blood pressure reduction, smoking, physical inactivity, body mass index, diabetes mellitus, sex differences in mortality
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Revascularization, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.